Abstract:Background Glycated albumin is the predominant circulating Amadori-type glycated protein in vivo and plays a major role in the development of diabetic vascular complications. The aim of this study was to assess the relationship between increased serum glycated albumin level and the presence and severity of coronary artery disease (CAD) in patients with type 2 diabetes mellitus (T2DM).Methods and Results In a total of 320 consecutive patients with T2DM, coronary angiography revealed normal coronary arteries in 83 patients (control group) and significant coronary stenosis (>= 70% luminal diameter narrowing) in 237, of whom 51 patients had 1-vessel disease (Group I), 80 had 2-vessel disease (Group II), and 106 had 3-vessel disease (Group III). Serum glycated albumin, hemoglobin Alc (HbAlc) and tumor necrosis factor (TNF)-alpha levels, lipid profile, and renal function were measured. Logistic regression analysis was performed to determine the relative risk of serum glycated albumin level for the presence and severity of CAD. Multivariate stepwise linear regression analysis was done to identify independent determinants of the glycated albumin level. Serum glycated albumin (21.2 +/- 5.3% vs 19.4 +/- 4.3%, p=0.005) and TNF-alpha levels (123 +/- 115 pg/ml vs 65 +/- 59 pg/ml, p < 0.001) were significantly higher in patients with CAD than in controls, but serum HbAlc level did not significantly differ between them (7.6 +/- 1.3% vs 7.4 +/- 1.2%, p=0.19). There was a significant difference in serum glycated albumin level between Groups I and III (19.5 +/- 3.3% vs 21.8 +/- 5.7%, p < 0.001). The serum glycated albumin level correlated with the number of diseased arteries (Spearman r=0.205, p < 0.001), and was closely related to serum levels on admission of glucose (r=0.495, p < 0.001), TNF-alpha (r=0.123, p=0.028), blood urea nitrogen (r=0.167, p=0.004), triglycerides (r=0.129, p=0.021), and HbAlc (r=0.795, p < 0.001). Multivariate analysis indicated that serum levels of glucose (p < 0.0001), TNF-alpha (p=0.001), blood urea nitrogen (p=0.004) and triglycerides (p=0.035) were independent determinants for glycated albumin. Logistic regression analysis revealed that glycated albumin >= 19% (odds ratio (OR) 2.9, p < 0.001) was an independent predictor for CAD and glycated albumin >= 21% (OR 2.3, p=0.032) for 3-vessel disease prediction. The area under the receiver-operating characteristic curve for glycated albumin (0.620, 95% confidence interval (CI) 0.548 to 0.691, p=0.001) was superior to that for HbAlc (0.543, 95% CI 0.473 to 0.613, p=0.243).Conclusions An increased serum level of glycated albumin is associated with the presence and severity of CAD, and may be useful in screening patients with T2DM.

Serum Legumain Is Associated with Peripheral Artery Disease in Patients with Type 2 Diabetes

Role of legumain in metabolic dysfunction, diagnosis, and prognosis of patients with atherosclerosis

Association between high plasma levels of legumain and cardiovascular events in patients undergoing coronary angiography

Serum lipoprotein (a)in hospitalized patients with type 2 diabetes mellitus and its association with diabetic nephropathy

[Association Between Serum Uric Acid Level and Peripheral Vascular Disease of Lower Extremities in Type 2 Diabetes Mellitus Subjects].

Related Factors of Lower Extremity Artery Disease in Type 2 Diabetic Inpatients

[Relationship Between Serum Β2-Microglobulin and Lower Extremity Atherosclerotic Occlusive Disease].

Lipoprotein-associated Phospholipase A2 is a Risk Factor for Diabetic Kidney Disease.

Association Between Plasma LRG1 and Lower Cognitive Function in Asians With Type 2 Diabetes Mellitus

Association between Lipoprotein(a) and diabetic nephropathy in patients with type 2 diabetes

Increased Serum Glycated Albumin Level Is Associated With The Presence And Severity Of Coronary Artery Disease In Type 2 Diabetic Patients

High Serum Galectin-3 Level as a Potential Biomarker of Peripheral Artery Disease in Patients Undergoing Hemodialysis

Role of lymphocyte-to-monocyte ratio as a predictive marker for diabetic coronary artery disease: A cross-sectional study

The Association of Elevated Serum Lipocalin 2 Levels with Diabetic Peripheral Neuropathy in Type 2 Diabetes

Correlation between circulating lipoprotein(a) levels and cardiovascular events risk in patients with type 2 diabetes

Association of Plasma Leucine-Rich Alpha-2 Glycoprotein 1 (LRG1) with All-Cause and Cause-Specific Mortality in Individuals with Type 2 Diabetes

Positive Association Between Urinary Albumin-Creatinine Ratio and Lower Extremity Peripheral Arterial Disease in Chinese Diabetes Patients: A Cross-Section Study with Propensity Score Matching Analysis

Serum Adiponectin Levels Are Positively Associated With Diabetic Peripheral Neuropathy in Chinese Patients With Type 2 Diabetes

Lower extremity arterial plaque in patients with type 2 diabetes mellitus: A cross-sectional study of 25-(OH)D3 and other risk factors

Increased plasma D-dimer levels may be a promising indicator for diabetic peripheral neuropathy in type 2 diabetes